Wespac Advisors So Cal, LLC Baxter International Inc Transaction History

Wespac Advisors So Cal, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 25, 2023	SELL	$49.7 - $57.71 $111,825 - $129,847	-2,250 Reduced 30.73%	5,072 $0
Q3 2022 Nov 10, 2022	SELL	$53.86 - $66.8 $27,953 - $34,669	-519 Reduced 6.62%	7,322 $398,000
Q2 2022 Jul 19, 2022	SELL	$63.83 - $80.0 $72,447 - $90,800	-1,135 Reduced 12.64%	7,841 $504,000
Q1 2022 May 19, 2022	SELL	$76.85 - $89.45 $46,110 - $53,670	-600 Reduced 6.27%	8,976 $696,000
Q4 2021 Feb 03, 2022	SELL	$74.57 - $87.19 $4.96 Million - $5.8 Million	-66,549 Reduced 87.42%	9,576 $813,000
Q4 2021 Feb 02, 2022	BUY	$74.57 - $87.19 $4.98 Million - $5.83 Million	66,809 Added 717.14%	76,125 $7.84 Million
Q3 2021 Oct 14, 2021	SELL	$73.77 - $83.61 $17,704 - $20,066	-240 Reduced 2.51%	9,316 $753,000
Q2 2021 Jul 29, 2021	SELL	$80.5 - $88.01 $32,200 - $35,204	-400 Reduced 4.02%	9,556 $769,000
Q4 2020 Feb 02, 2021	SELL	$75.39 - $82.36 $18,847 - $20,590	-250 Reduced 2.45%	9,956 $799,000
Q3 2020 Oct 23, 2020	SELL	$78.33 - $90.73 $46,528 - $53,893	-594 Reduced 5.5%	10,206 $801,000
Q2 2020 Jul 17, 2020	SELL	$78.66 - $94.14 $29,497 - $35,302	-375 Reduced 3.36%	10,800 $920,000
Q1 2020 Apr 30, 2020	SELL	$71.57 - $93.3 $45,089 - $58,779	-630 Reduced 5.34%	11,175 $1.04 Million
Q4 2019 Feb 13, 2020	SELL	$76.7 - $88.45 $23,010 - $26,535	-300 Reduced 2.48%	11,805 $987,000
Q2 2019 Jul 30, 2019	BUY	$73.44 - $82.41 $852,271 - $956,368	11,605 Added 2321.0%	12,105 $991,000
Q3 2018 Oct 22, 2018	BUY	$70.71 - $77.75 $35,355 - $38,875	500 New	500 $38,000

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.3B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.